Skystar Bio-Pharmaceutical Company Debt to Equity Ratio:

0.0594 for Dec. 31, 2012
View Full Chart

Skystar Bio-Pharmaceutical Company Debt to Equity Ratio Chart

    Skystar Bio-Pharmaceutical Company Historical Debt to Equity Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.0594
    Sept. 30, 2012 0.1087
    June 30, 2012 0.0728
    March 31, 2012 0.0826
    Dec. 31, 2011 0.0836
    Sept. 30, 2011 0.0394
    June 30, 2011 0.055
    March 31, 2011 0.0583
    Dec. 31, 2010 0.0423
    Sept. 30, 2010 0.026
    June 30, 2010 0.00
    March 31, 2010 0.002
    Dec. 31, 2009 0.0041
    Sept. 30, 2009 0.0065
    June 30, 2009 0.0399
    March 31, 2009 0.0411
    Dec. 31, 2008 0.0397
    Sept. 30, 2008 0.0294
    June 30, 2008 0.00
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    March 31, 2000 Go Pro

    About Debt to Equity Ratio

    Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

    A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

    It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
    Learn More

    Get data for

    SKBI Debt to Equity Ratio Benchmarks

    Companies
    GlaxoSmithKline 2.886
    Tetraphase Pharmaceuticals
    Zoetis 0.1446

    SKBI Debt to Equity Ratio Rankings

    Overall 78th percentile
    1656 of 7590
    Sector 58th percentile
    272 of 651 in Healthcare
    Industry 67th percentile
    17 of 52 in Drug Manufacturers - Major

    SKBI Debt to Equity Ratio Range, Past 5 Years

    Minimum 0.00 Jun 2008
    Maximum 0.1087 Sep 2012
    Average 0.0416